ReviewiScience2026
Advanced biomaterial strategies for cancerous wound management from palliative to multifunctional platforms.
Review in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancerous wounds cause severe pain, odor, exudate, and bleeding, severely impairing patients' quality of life. Traditional management focuses on palliative symptom control. However, advances in biomaterials, drug delivery, and immunomodulation are transforming wound dressings from passive coverings into multifunctional therapeutic platforms. This review systematically outlines contemporary strategies for cancer wound management, covering evidence-based conventional dressings and emerging smart technologies, including injectable hydrogels, nanocomposites, and bioactive materials. These innovations not only control core symptoms but also demonstrate local immune modulation and antitumor activity. The paper further analyzes clinical translation challenges and outlines future directions, aiming to advance cancer wound management from palliative care toward integrated therapeutic models.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.